ORMP

ORAMED PHARMACEUTICALS INC

ORMP·68403P203·US·Common Stock·Healthcare - Biotechnology-Activist

ORMP (ORAMED PHARMACEUTICALS INC) is held by 38 institutional investors as of Q1 2026. Largest holders: MERCER GLOBAL ADVISORS INC /ADV ($6.5M), MARSHALL WACE, LLP ($882,677), Rathbones Group PLC ($792,261). Net institutional sentiment: Mixed.

38
Holders
(3 Elite)
$13.2M
Total Value
59% (37)
Consensus
22 buying - 15 selling
13F: Insider & Congress:
ORMP

Smart Money Verdict

View all
Held by 38 funds
3 elite

Who's Trading

ActivistLBLeonard Braden Michael2.5%Jun 29, 2026
ActivistAFAquamarine Financial (Cayman) Ltd5.1%May 15, 2026
ActivistBIBML Investment Partners, L.P.7.9%Feb 9, 2026
ActivistNKNadav Kidron7.6%Aug 28, 2025
CongressBrad KnottBrad KnottSale $15,001 - $50,000Jan 10, 2025

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
1.9M$6.5M0.0%+27.22%
38
Increased
259,611(+0.2%)$882,6770.0%+64.02%
25
Unchanged
233,018$792,2610.0%+76.95%
0
Increased
158,209(+5.1%)$537,7350.0%+87.72%
26
Increased
157,586(+20.7%)$535,7910.0%+61.81%
29
Increased
147,700(+0.1%)$502,1800.0%+85.81%
24
Increased
146,152(+2.8%)$496,9160.0%+93.99%
17
Increased
136,218(+424.2%)$463,1410.0%+32.77%
39
New
116,363$395,6340.0%+27.22%
33
Decreased
98,629(-49.7%)$335,3380.0%+84.44%
0
Increased
92,192(+2.2%)$313,4530.0%+89.31%
16
Decreased
52,540(-32.9%)$178,6360.0%+58.76%
0
New
51,670$175,6780.0%+27.22%
31
Increased
50,207(+14.8%)$170,7040.0%+69.05%
26
Increased
32,307(+64.9%)$109,8440.0%+37.36%
32
Increased
26,052(+2.4%)$88,5770.0%+63.01%
22
Unchanged
24,282$82,5580.0%-52.98%
0
New
23,504$79,9140.0%+27.22%
30
Decreased
22,688(-40.6%)$77,1390.0%+68.14%
0
Unchanged
21,200$72,0800.0%+7.67%
0

Showing 1-20 of 42

1 / 3
ORMPORMPORAMED PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used